• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病的临床表现及分子背景:基于家族性和人群研究中发现的基因

Clinical Manifestations and Molecular Backgrounds of Parkinson's Disease Regarding Genes Identified From Familial and Population Studies.

作者信息

Nishioka Kenya, Imai Yuzuru, Yoshino Hiroyo, Li Yuanzhe, Funayama Manabu, Hattori Nobutaka

机构信息

Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.

Department of Research for Parkinson's Disease, Juntendo University Graduate School of Medicine, Tokyo, Japan.

出版信息

Front Neurol. 2022 Jun 2;13:764917. doi: 10.3389/fneur.2022.764917. eCollection 2022.

DOI:10.3389/fneur.2022.764917
PMID:35720097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9201061/
Abstract

Over the past 20 years, numerous robust analyses have identified over 20 genes related to familial Parkinson's disease (PD), thereby uncovering its molecular underpinnings and giving rise to more sophisticated approaches to investigate its pathogenesis. α-Synuclein is a major component of Lewy bodies (LBs) and behaves in a prion-like manner. The discovery of α-Synuclein enables an in-depth understanding of the pathology behind the generation of LBs and dopaminergic neuronal loss. Understanding the pathophysiological roles of genes identified from PD families is uncovering the molecular mechanisms, such as defects in dopamine biosynthesis and metabolism, excessive oxidative stress, dysfunction of mitochondrial maintenance, and abnormalities in the autophagy-lysosome pathway, involved in PD pathogenesis. This review summarizes the current knowledge on familial PD genes detected by both single-gene analyses obeying the Mendelian inheritance and meta-analyses of genome-wide association studies (GWAS) from genome libraries of PD. Studying the functional role of these genes might potentially elucidate the pathological mechanisms underlying familial PD and sporadic PD and stimulate future investigations to decipher the common pathways between the diseases.

摘要

在过去20年里,大量有力的分析已鉴定出20多个与家族性帕金森病(PD)相关的基因,从而揭示了其分子基础,并催生了更复杂的方法来研究其发病机制。α-突触核蛋白是路易小体(LBs)的主要成分,其行为类似朊病毒。α-突触核蛋白的发现使人们能够深入了解路易小体形成和多巴胺能神经元丢失背后的病理机制。了解从帕金森病家族中鉴定出的基因的病理生理作用,正在揭示参与帕金森病发病机制的分子机制,如多巴胺生物合成和代谢缺陷、过度氧化应激、线粒体维持功能障碍以及自噬-溶酶体途径异常。本综述总结了通过遵循孟德尔遗传的单基因分析以及对帕金森病基因组文库进行全基因组关联研究(GWAS)的荟萃分析所检测到的家族性帕金森病基因的现有知识。研究这些基因的功能作用可能有助于阐明家族性帕金森病和散发性帕金森病的病理机制,并推动未来的研究以破译这两种疾病之间的共同途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5550/9201061/5395676da8c8/fneur-13-764917-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5550/9201061/45576cbdbaaf/fneur-13-764917-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5550/9201061/5395676da8c8/fneur-13-764917-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5550/9201061/45576cbdbaaf/fneur-13-764917-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5550/9201061/5395676da8c8/fneur-13-764917-g0002.jpg

相似文献

1
Clinical Manifestations and Molecular Backgrounds of Parkinson's Disease Regarding Genes Identified From Familial and Population Studies.帕金森病的临床表现及分子背景:基于家族性和人群研究中发现的基因
Front Neurol. 2022 Jun 2;13:764917. doi: 10.3389/fneur.2022.764917. eCollection 2022.
2
The central theme of Parkinson's disease: α-synuclein.帕金森病的核心主题:α-突触核蛋白。
Mol Neurobiol. 2013 Apr;47(2):460-5. doi: 10.1007/s12035-012-8369-3. Epub 2012 Nov 23.
3
Genes Link Mitochondrial Dysfunction and Alpha-Synuclein Pathology in Sporadic Parkinson's Disease.基因将散发性帕金森病中的线粒体功能障碍与α-突触核蛋白病理学联系起来。
Front Cell Dev Biol. 2021 Jul 6;9:612476. doi: 10.3389/fcell.2021.612476. eCollection 2021.
4
Genetic insights into sporadic Parkinson's disease pathogenesis.遗传性散发性帕金森病发病机制的研究进展。
Curr Genomics. 2013 Dec;14(8):486-501. doi: 10.2174/1389202914666131210195808.
5
Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.重印本:重新探讨氧化应激和线粒体功能障碍在帕金森病发病机制中的作用——类似于安非他命类药物滥用的影响。
Free Radic Biol Med. 2013 Sep;62:186-201. doi: 10.1016/j.freeradbiomed.2013.05.042. Epub 2013 Jun 3.
6
Current perspective of mitochondrial biology in Parkinson's disease.帕金森病中线粒体生物学的当前观点。
Neurochem Int. 2018 Jul;117:91-113. doi: 10.1016/j.neuint.2018.03.001. Epub 2018 Mar 14.
7
Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.帕金森病中五个孟德尔基因及全基因组关联研究中顶级基因的重测序分析。
Mol Neurodegener. 2016 Apr 19;11:29. doi: 10.1186/s13024-016-0097-0.
8
A tangled web - tau and sporadic Parkinson's disease.一团乱麻——tau 蛋白与散发性帕金森病。
Front Psychiatry. 2010 Dec 27;1:150. doi: 10.3389/fpsyt.2010.00150. eCollection 2010.
9
Vesicular Dysfunction and the Pathogenesis of Parkinson's Disease: Clues From Genetic Studies.囊泡功能障碍与帕金森病的发病机制:来自遗传学研究的线索
Front Neurosci. 2020 Jan 8;13:1381. doi: 10.3389/fnins.2019.01381. eCollection 2019.
10
Diversity of pathological features other than Lewy bodies in familial Parkinson's disease due to SNCA mutations.由SNCA突变导致的家族性帕金森病中除路易小体外的病理特征多样性。
Am J Neurodegener Dis. 2013 Nov 29;2(4):266-75. eCollection 2013.

引用本文的文献

1
PADG-Pred: Exploring Ensemble Approaches for Identifying Parkinson's Disease Associated Biomarkers Using Genomic Sequences Analysis.PADG-Pred:利用基因组序列分析探索用于识别帕金森病相关生物标志物的集成方法。
IET Syst Biol. 2025 Jan-Dec;19(1):e70006. doi: 10.1049/syb2.70006.
2
Common genetic risk for Parkinson's disease and dysfunction of the endo-lysosomal system.帕金森病的常见遗传风险与内溶酶体系统功能障碍。
Philos Trans R Soc Lond B Biol Sci. 2024 Apr 8;379(1899):20220517. doi: 10.1098/rstb.2022.0517. Epub 2024 Feb 19.
3
Genetics in Parkinson's disease, state-of-the-art and future perspectives.

本文引用的文献

1
Rapid motor progression of Parkinson's disease associates with clinical and genetic variants.帕金森病的快速运动进展与临床和遗传变异有关。
Front Biosci (Landmark Ed). 2021 Dec 30;26(12):1503-1512. doi: 10.52586/5044.
2
Genotype-Phenotype Relations for the Atypical Parkinsonism Genes: MDSGene Systematic Review.非典型帕金森病基因的基因型-表型关系:MDSGene 系统评价。
Mov Disord. 2021 Jul;36(7):1499-1510. doi: 10.1002/mds.28517. Epub 2021 Mar 19.
3
R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils.
帕金森病的遗传学:现状与未来展望。
Br Med Bull. 2024 Mar 13;149(1):60-71. doi: 10.1093/bmb/ldad035.
4
Dopamine Signaling in Substantia Nigra and Its Impact on Locomotor Function-Not a New Concept, but Neglected Reality.黑质多巴胺信号及其对运动功能的影响——并非新概念,而是被忽视的现实。
Int J Mol Sci. 2024 Jan 17;25(2):1131. doi: 10.3390/ijms25021131.
5
The Role of Immune Dysfunction in Parkinson's Disease Development.免疫功能障碍在帕金森病发展中的作用。
Int J Mol Sci. 2023 Nov 26;24(23):16766. doi: 10.3390/ijms242316766.
6
Role of α-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson's disease.α-突触核蛋白在小胶质细胞中的作用:自噬和吞噬作用平衡帕金森病中的神经炎症。
Inflamm Res. 2023 Mar;72(3):443-462. doi: 10.1007/s00011-022-01676-x. Epub 2023 Jan 4.
R1441G 突变而非 G2019S 突变增强了人外周血中性粒细胞中 LRRK2 介导的 Rab10 磷酸化。
Acta Neuropathol. 2021 Sep;142(3):475-494. doi: 10.1007/s00401-021-02325-z. Epub 2021 Jun 14.
4
Decreased glucocerebrosidase activity and substrate accumulation of glycosphingolipids in a novel GBA1 D409V knock-in mouse model.新型 GBA1 D409V 基因敲入小鼠模型中葡萄糖脑苷脂酶活性降低和糖鞘脂类底物蓄积。
PLoS One. 2021 Jun 9;16(6):e0252325. doi: 10.1371/journal.pone.0252325. eCollection 2021.
5
Enhancer release and retargeting activates disease-susceptibility genes.增强子释放和重新靶向激活疾病易感性基因。
Nature. 2021 Jul;595(7869):735-740. doi: 10.1038/s41586-021-03577-1. Epub 2021 May 26.
6
Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease.LRRK2 帕金森病修饰物的全基因组关联研究。
Ann Neurol. 2021 Jul;90(1):76-88. doi: 10.1002/ana.26094. Epub 2021 May 17.
7
VPS13D bridges the ER to mitochondria and peroxisomes via Miro.VPS13D 通过 Miro 将内质网与线粒体和过氧化物酶体连接起来。
J Cell Biol. 2021 May 3;220(5). doi: 10.1083/jcb.202010004.
8
VPS13D promotes peroxisome biogenesis.VPS13D 促进过氧化物酶体的生物发生。
J Cell Biol. 2021 May 3;220(5). doi: 10.1083/jcb.202001188.
9
A Novel SNCA A30G Mutation Causes Familial Parkinson's Disease.一种新型 SNCA A30G 突变导致家族性帕金森病。
Mov Disord. 2021 Jul;36(7):1624-1633. doi: 10.1002/mds.28534. Epub 2021 Feb 22.
10
Clinical manifestations of Parkinson's disease harboring VPS35 retromer complex component p.D620N with long-term follow-up.携带VPS35逆向转运蛋白复合体成分p.D620N的帕金森病的临床表现及长期随访
Parkinsonism Relat Disord. 2021 Mar;84:139-143. doi: 10.1016/j.parkreldis.2021.02.014. Epub 2021 Feb 13.